Dual blocking of PI3K and mTOR signaling by DHW‐221, a novel benzimidazole derivative, exerts antitumor activity in human non‐small cell lung cancer
Guardado en:
Autores principales: | Xiaochun Qin, Mingyue Liu, Yuting Wu, Shu Wang, Siheng Lian, Hui Jia, Qiong Wu, Huaiwei Ding, Qingchun Zhao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/21cb541f36864d17bed03e910e24f1a7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
por: Eun Jin Sun, et al.
Publicado: (2021) -
Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathway
por: Xiangjin Zheng, et al.
Publicado: (2021) -
Combined PI3Kα-mTOR Targeting of Glioma Stem Cells
por: Frank D. Eckerdt, et al.
Publicado: (2020) -
Role of PTEN, PI3K, and mTOR in Triple-Negative Breast Cancer
por: Mirjana Prvanović, et al.
Publicado: (2021) -
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
por: R. Reilly, et al.
Publicado: (2017)